Occupational Therapists in Tavernier, FL Accepting Medicare
4 Occupational Therapists found. Showing 1 - 4
 Jaquita Beth Jones, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 92410 Overseas Hwy, Suite 6, Tavernier, FL 33070 Phone: 305-852-8600 Fax: 305-852-8300 |
Tiffany Lee Mcnew, MS, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 48 High Point Rd, Tavernier, FL 33070 Phone: 305-853-0799 |
Brenda K Ewer, OT Occupational Therapist - Hand Medicare: Not Enrolled in Medicare Practice Location: 200 Florida Ave, Tavernier, FL 33070 Phone: 305-853-0943 |
Mrs. Allison Heather Glaze, MS, OTR/L, LMT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 92410 Overseas Hwy, Suite 6, Tavernier, FL 33070 Phone: 305-852-8600 Fax: 305-852-8300 |
News Archive
West Nile Virus threat continues in Pennsylvania
Department of Environmental Protection Secretary John Hanger today reminded Pennsylvania's citizens that although the number of West Nile Virus cases has dropped, the threat still exists.
Democrats still wonder: Run on health reform or against it?
The Fiscal Times reports that some Democrats are trying to decide whether they should run for re-election on health reform or against it. "A new poll suggests it's not so clear-cut, and some Democrats seem to agree.
Product to assist bone formation in spinal fusion surgery released by DePuy Synthes
DePuy Synthes*, in collaboration with LifeNet Health®, launches ViviGen Formable™ Cellular Bone Matrix**, a second generation cellular allograft used to assist in the formation of bone during spinal fusion surgery. ViviGen Formable augments the DePuy Synthes biomaterials portfolio and joins the first generation, ViviGen® Cellular Bone Matrix, which launched in late 2014. With both ViviGen and ViviGen Formable, surgeons may now choose a preferred handling option based on the needs of each surgical case.
Acid suppression drugs frequently prescribed for high-risk newborns, study shows
Since 2006, several published studies have associated the use of some acid suppression medications in hospitalized high-risk babies with infections, necrotizing enterocolitis and increased risk of death. Those medications - histamine-2 receptor antagonists, such as ranitidine (Zantac and others), and proton pump inhibitors, such as esomeprazole (Nexium and others) - were originally approved by the U.S. Food and Drug Administration for use in adults and older children.
NPS Pharmaceuticals closes public offering of 7,912,000 common stock shares
NPS Pharmaceuticals, Inc. today announced the closing of a public offering of 7,912,000 shares of its common stock, including 1,032,000 shares sold pursuant to the full exercise of an overallotment option previously granted to the underwriters. Net proceeds were approximately $44.4 million after deducting underwriting discounts and estimated offering expenses. Jefferies & Company, Inc. acted as the sole book-running manager and Canaccord Genuity Inc. acted as co-lead manager for the offering.
› Verified 2 days ago
Podiatrists
Chiropractors
Physical Therapists
Occupational Therapists
Optometrists
Speech-Language Pathologists